ERANID, the European Research Area Network on Illicit Drugs, is an ERA-NET programme. The infrastructure is funded by the European Committee under FP7. The consortium consists of 9 organisations in 6 different EU Member States:
The network aims to improve cooperation in drug research in order to allow well-founded policy decisions, prevention and harm reduction interventions. ERANID is meant as a first step towards a longer term transnational cooperation in the field of drugs research.
ERANID works both in the demand field and in the supply field. It promotes multidisciplinary research activities in the field of socio-economic sciences and humanities. This may cover e.g.:
It may also cover patterns in drug markets and the drug-crime nexus. Closer cooperation between researchers in different countries will also lead to a further development of research methodologies, which can be of special importance for the evaluation of policies and programmes.
The Strategic Research Agenda (SRA) is the basis of the content of 2 transnational calls. The stocktaking of research projects/programmes and policies in the participating countries has been made easy accessible on the ERANID website and will help researchers and policy makers to find information and avoid unnecessary duplication of research.
The first joint call for proposals, entitled 'Understanding drug use pathways', resulted in 3 funded projects. In the second call for proposals, entiteld 'Society and responses to drug use', 4 project are funded.
An online ERANID database has been published. This database contains information gathered in the course of the ERANID project during 2013 and 2014. Principally, it contains details of research projects on illicit drugs carried out since 2010 within the 6 ERANID countries and funded by the European Committee: Belgium, France, Italy, Portugal, The Netherlands and The United Kingdom. However, this database will not capture all illicit drugs research carried out within a country.
Online ERANID database
More information is available on the ERANID website: www.eranid.eu.